Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to Interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML)

The majority of chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs) remain with residual disease. In contrast to TKIs, interferon (IFN) is directly toxic to CML progenitor cells, and myeloid growth factors such as GM-CSF may enhance IFN’s cytotoxicity. We performed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zeidner, Joshua F, Gladstone, Douglas E, Zahurak, Marianna, Matsui, William H, Gocke, Christopher, Jones, Richard J, Smith, B Douglas
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4135379/
https://ncbi.nlm.nih.gov/pubmed/25012565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2014.05.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados